Patents by Inventor Jeffrey Luo

Jeffrey Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180355043
    Abstract: The present invention relates antibodies or antigen-binding fragments thereof specifically binding HLA-DR, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.
    Type: Application
    Filed: December 16, 2016
    Publication date: December 13, 2018
    Inventors: Christian Martinez, Qiang Chen, Melissa Swiecki, Robert Kuhn, Hong Zhou, Karen Duffy, Stephane Becart, Chichi Huang, Xiefan Lin-Schmidt, Sheng-Jiun Wu, Jeffrey Luo, Galina Obmolova, Robin Ernst
  • Patent number: 7910101
    Abstract: Melanocortin receptor binding mimetibody polypeptides are disclosed. Polynucleotides encoding these polypeptides, cells comprising these polynucleotides or expressing the mimetibodies, and methods of making and using the forgoing are also disclosed.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 22, 2011
    Assignee: Centocor, Inc.
    Inventors: Mark Cunningham, Vedrana Stojanovic-Susulic, Karyn O'Neil, Chichi Huang, Jeffrey Luo
  • Patent number: 7659250
    Abstract: Human Bone Morphogenic Protein 7 (hBMP-7) variant peptide chains, nucleic acids encoding these peptide chains, and methods of making and using the foregoing are disclosed.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: February 9, 2010
    Assignee: Centocor, Inc.
    Inventors: Bernard Amegadzie, Mark Cunningham, Haimanti Dorai, Jeffrey Luo, Juliane Mills, Bethany Swencki-Underwood
  • Publication number: 20090186020
    Abstract: Melanocortin receptor binding mimetibody polypeptides are disclosed. Polynucleotides encoding these polypeptides, cells comprising these polynucleotides or expressing the mimetibodies, and methods of making and using the forgoing are also disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 23, 2009
    Inventors: Mark Cunningham, Vedrana Stojanovic-Susulic, Karyn O'Neil, Chichi Huang, Jeffrey Luo
  • Publication number: 20080038831
    Abstract: An anti-IL-23 specific human Ig derived protein, isolated nucleic acids that encode at least one anti-IL-23 Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof are useful as therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably binds to one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
    Type: Application
    Filed: June 26, 2007
    Publication date: February 14, 2008
    Inventors: Jacqueline Benson, Mark Cunningham, Jeffrey Luo
  • Publication number: 20080032919
    Abstract: Human Bone Morphogenic Protein 7 (hBMP-7) variant peptide chains, nucleic acids encoding these peptide chains, and methods of making and using the foregoing are disclosed.
    Type: Application
    Filed: June 8, 2007
    Publication date: February 7, 2008
    Inventors: Bernard Amegadzie, Mark Cunningham, Haimanti Dorai, Jeffrey Luo, Juliane Mills, Bethany Swencki-Underwood
  • Patent number: 7252971
    Abstract: An anti-IL-23 specific human Ig derived protein is useful in therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably includes one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: August 7, 2007
    Assignee: Centocor, Inc.
    Inventors: Jacqueline Benson, Mark Cunningham, Jeffrey Luo
  • Publication number: 20060105951
    Abstract: Melanocortin receptor binding mimetibody polypeptides are disclosed. Polynucleotides encoding these polypeptides, cells comprising these polynucleotides or expressing the mimetibodies, and methods of making and using the forgoing are also disclosed.
    Type: Application
    Filed: October 25, 2005
    Publication date: May 18, 2006
    Inventors: Mark Cunningham, Vedrana Stojanovic-Susulic, Karyn O'Neil, Chichi Huang, Jeffrey Luo
  • Publication number: 20060067936
    Abstract: An anti-IL-23 specific human Ig derived protein, isolated nucleic acids that encode at least one anti-IL-23 Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof are useful as therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably binds to one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.
    Type: Application
    Filed: September 23, 2005
    Publication date: March 30, 2006
    Inventors: Jacqueline Benson, Mark Cunningham, Jeffrey Luo